COVID–19 and neurodegenerative diseases

Abstract

Coronavirus disease 2019 (COVID–19) associated with SARS–CoV–2 virus infection is often associated with neuromuscular symptoms, although it is mainly characterized by respiratory symptoms. In this article, I present movement disorders associated with COVID–19 including myoclonus, tremor, parkinsonism, and ataxia. These findings are presumed to be caused by immune–mediated pathogenesis after infection. Because the reports on the effects of COVID–19 in the treatment of neurodegenerative diseases are almost limited to Parkinson's disease, the effects of COVID–19 on the motor and non–motor symptoms of Parkinson's disease and some important points to consider in clinical practice are presented.